AAV Gene Therapy: Discovery and Optimization
Viral vectors, such as AAV, have emerged as one of the most commonly used gene delivery vehicles. In this webinar, our speakers discuss how WuXi AppTec can help teams engineer and optimize viral vectors, and how best to utilize a range of in vitro and in vivo assays in our services platform to support the discovery stages of a viral gene therapy program. In addition, our experts present methods for fast, scalable, and cost-effective viral vector production.
Related Content
Gene therapies are enabling a rapid expansion in the scope of treatable disease. Adeno-associated viruses (AAVs) are particularly advantageous delivery...
VIEW RESOURCEAdvances in the understanding of rare disease biology, coupled with innovative technology and therapeutic platforms, has led to progress in...
VIEW RESOURCE